Protein tyrosine phosphatase, non-receptor type 9 (PTPN9) is a soluble tyrosine phosphatase that attenuates prolactin- and EGF-mediated STAT5 activation, which regulates expression of genes that promote cell survival and proliferation in breast cancer cells [12]. Here, EGF is linked to breast carcinoma.